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Abstract
Background: In maternal medicine, research evidence is scattered making it difficult to access
information for clinical decision making. Systematic reviews of good methodological quality are
essential to provide valid inferences and to produce usable evidence summaries to guide
management. This review assesses the methodological features of existing systematic reviews in
maternal medicine, comparing Cochrane and non-Cochrane reviews in maternal medicine.
Methods: Medline, Embase, Database of Reviews of Effectiveness (DARE) and Cochrane Database
of Systematic Reviews (CDSR) were searched for relevant reviews published between 2001 and
2006. We selected those reviews in which a minimum of two databases were searched and the
primary outcome was related to the maternal condition. The selected reviews were assessed for
information on framing of question, literature search and methods of review.
Results: Out of 2846 citations, 68 reviews were selected. Among these, 39 (57%) were Cochrane
reviews. Most of the reviews (50/68, 74%) evaluated therapeutic interventions. Overall, 54/68
(79%) addressed a focussed question. Although 64/68 (94%) reviews had a detailed search
description, only 17/68 (25%) searched without language restriction. 32/68 (47%) attempted to
include unpublished data and 11/68 (16%) assessed for the risk of missing studies quantitatively. The
reviews had deficiencies in the assessment of validity of studies and exploration for heterogeneity.
When compared to Cochrane reviews, other reviews were significantly inferior in specifying
questions (OR 20.3, 95% CI 1.1–381.3, p = 0.04), framing focussed questions (OR 30.9, 95% CI 3.7256.2, p = 0.001), use of unpublished data (OR 5.6, 95% CI 1.9–16.4, p = 0.002), assessment for
heterogeneity (OR 38.1, 95%CI 2.1, 688.2, p = 0.01) and use of meta-analyses (OR 3.7, 95% CI 1.3–
10.8, p = 0.02).
Conclusion: This study identifies areas which have a strong influence on maternal morbidity and
mortality but lack good quality systematic reviews. Overall quality of the existing systematic
reviews was variable. Cochrane reviews were of better quality as compared to other reviews.
There is a need for good quality systematic reviews to inform practice in maternal medicine.
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Background
Maternal medicine has emerged as an increasingly important area for the obstetricians dealing with high risk pregnancies. It involves care of women with medical
complications of pregnancy which may be specific to or
predate the pregnancy [1]. Approximately half of complex
pregnancies are related to an abnormal fetal or obstetric
factor, whereas medical diseases constitute the remainder
of this high risk obstetric population. Scientific developments in internal or general medicine have led to newer
diagnostic and therapeutic strategies to manage medical
diseases. The physiological changes during pregnancy can
affect not only the clinical presentation of a medical problem but may give rise to difficulties in diagnosing and
managing these problems. In order to provide the best
possible quality of care to women with complicated pregnancies obstetricians dealing with the high risk obstetric
cases should have evidence based knowledge on the diagnostic, therapeutic and prognostic aspects of maternal
medicine.
Recently there has been a proliferation of systematic
reviews as one of the key tools for evidence-based medicine [2]. As maternal medicine covers the issues related to
pregnancy as well as general medicine, research evidence
is scattered in the literature making it difficult to access
information for clinical decision making. Systematic
reviews provide a way forward as individual pieces of
research can be collected within literature reviews and if
appropriate subjected to meta-analysis [3]. Good methodological quality is essential for these reviews to have valid
inferences and to produce usable evidence summaries to
guide the obstetric management [4]. This study examines
the methodological features of recently published systematic reviews in maternal medicine and specifically compares Cochrane to non-Cochrane reviews.

Methods
To determine the quality of current systematic reviews in
maternal medicine, we developed a priori protocol based
on recommended methods [2,5-7].
A computerised search of publicly available databases was
conducted. Ovid Medline (1996 to date), Embase (1996
to date), Database of Reviews of Effectiveness and
Cochrane Database of Systematic Reviews were searched
for relevant reviews published between 2001 and 2006.
Key word combinations like Pregnan$, Matern$, Gestation$, Obstetric$, Complication$, Systematic review$ and
Meta analys$ were used for the search strategy in addition
to word variants, subject headings and free text. The $ sign
is a truncator used to capture any word that begin with the
letters in front of the $ sign in the search terms used. Additionally common and specific medical problems related
to pregnancy were searched using key words describing
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names of the disease such as Pre eclampsia, Hypertension,
Diabetes, Cholestasis, Anaemia, Thrombocytopaenia,
Thrombophilia, and Thromboembolism. Hand search of
reference lists was conducted of all relevant articles to
identify any missing reviews. The searches were limited to
reviews between 2001 and 2006 due to increasing developments in the field of maternal medicine in recent years.
Inclusion criteria required a minimum of two publicly
available databases searched for a medical condition specific to or predating pregnancy and maternal factor as the
primary outcome. We searched without language restrictions. All the reviews with fetal or neonatal factor as the
primary outcome were excluded.
Two reviewers independently extracted and assessed the
data according to a checklist formulated as part of our protocol (Table 1). The methodological quality of each
review was assessed by focussing on framing of the question, literature search and review methods scrutinising
methods of literature search and data synthesis. The items
assessed internal validity and explicitness of reporting,
both of which are important issues in quality of reviews.
Differences between reviewers were resolved by discussion. We computed rates of compliance with the items in
our checklist and compared Cochrane and non-Cochrane
reviews. Odds ratios and their 95% confidence intervals
were computed. All statistical analysis was performed
using Stata 8.0 statistical package.

Results
The initial literature search resulted in 2864 citations. Of
these 68 reviews [8-75] fulfilled the inclusion criteria and
were selected for detailed study (Fig 1). A total of 39
(57%) Cochrane reviews [8-46] and 29 (43%) non
Cochrane reviews [47-75] were included. Most of the
reviews assessed therapeutic interventions (50/68, 74%),
and the rest were reviews on prognosis (12/68, 17%) and
diagnosis (6/68, 9%). The range of clinical topics dealt
with by the reviews is shown in Fig 2.
Overall quality of the existing systematic reviews was variable (Fig 3). Majority of the reviews (62/68, 91%) specified the question and 54/68 (79%) had a focussed
question with clearly defined population and outcome
measures. A large population of the reviews (64/68, 94%)
had a detailed search description including databases
searched and key words used. Almost half of the reviews
(32/68, 47%) attempted to include unpublished data.
However only 11/68 (16%) assessed the risk of missing
studies quantitatively and 17/68 (25%) searched without
language restriction. Almost all the reviews had good tabulation of results and characteristics of included studies
(65/68, 96%).
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Table 1: Checklist used to assess the quality of systematic
reviews included in the review.

Title
Reference
First Author
Year of publication
Journal
Publication dates of literature included
No. studies included in the review
No. of reviewers
Type of review
Framing of question:
Question specified
Question relevant
Narrow focus of question
Explicit testable hypothesis
Literature search
Adequate search description (incl. names of
databases and search terms)
Use of reference list
Search without language restriction
Assessment for risk of missing studies
Inclusion of unpublished data
Quality assessment of included studies:
Potential sources of bias (ie. randomisation)
Data collection (prospective/retrospective)
Follow-up
Blinding of assessors*
Description of intervention*

SEARCH STRATEGY
Electronic literature search in Medline,Embase, Cochrane and DARE combining terms (Pregnan$, matern$,
gestation$ OR Obstetrics) AND (medicine OR complication OR medic$) AND (systematic review$ OR metaanalysis)

Total citations
screened for relevance
n=2846

Citations excluded because they
did not meet selection
criteria
n=2643

therapeutic/
prognostic/diagnostic

Citations retrieved for more
detailed evaluation of full manuscripts
n=203

yes/no
yes/no
yes/no
yes/no

Studies excluded due to duplication,
non-systematic approach
(eg. clinical update), inappropriate
outcomes (eg. fetal), or inadequate
search strategy
n=135
Studies included in
Systematic review
n=68

yes/no
yes/no
yes/no
yes/no
yes/no
yes/no
yes/no
yes/no
yes/no
yes/no

Therapeutic reviews
n=50

Prognostic reviews
n=12

Diagnostic reviews
n=6

medicine
Search
methodological
Figure
strategy
1
and
features
studyofselection
systematic
process
reviews
forin
review
maternal
of the
Search strategy and study selection process for review of the
methodological features of systematic reviews in maternal
medicine.

*applicable only to interventional reviews

The quality of Cochrane and non Cochrane reviews is
given in Fig 3. Cochrane reviews [8-46] had specified the
questions more often than non Cochrane reviews [4751,53-55,58-60,62-71,73-75] (OR 20.3, 95% CI 1.1–
381.3, p = 0.04) and were also framed narrowly focussed
questions specifying the population, interventions and
comparisons, outcome of the study and the study design
(OR 30.9, 95% CI 3.7- 256.2, p = 0.001). Cochrane
reviews attempted more often to include unpublished
data in literature search (OR 5.6, 95% CI 1.9–16.4, p =
0.002). Twelve out of 29 non-Cochrane reviews
[48,50,53-55,64-66,68-71] performed a meta-analysis,
but there was good awareness of where this technique was
valuable and where it was not applicable. Meta analysis
technique (OR 3.7, 95% CI 1.3–10.8, p = 0.02) and
assessment for heterogeneity (OR 38.1, 95%CI 2.1, 688.2,
p = 0.01) was found to be employed significantly more
often by Cochrane reviews.

Review Topics in Maternal Medicine

Psychiatric disorders
(n=13, 20%)

Infective disorders
(n=6, 9%)

Haematological disease
(n=2, 3%)
Neurology
(n=1, 1%)
Endocrine disorders
(n=4, 6%)

Thromboembolic disease
(n=7, 10%)

Respiratory disease
(n=3, 4%)
Musculoskeletal
(n=2,3%)
Gastrointestinal tract disorders
(n=3, 4%)
Drugs
(n=1, 1%)

Discussion
Our study showed that the Cochrane reviews [8-46] were
of consistently high methodological quality and had a
greater level of assessment for quality of included studies.
They always did a meta-analysis [9,12,17,19-25,27-40,4446] where applicable. This is reassuring for clinicians who
rely on them for decision-making. It is possible that the

Urinary tract disorders
(n=2, 3%)

Hypertensive disorders
(n=23, 35%)

Hepatic disease
(n=1, 1%)

Total number of reviews=68

Figure topics
Clinical
2
covered by existing maternal medicine reviews
Clinical topics covered by existing maternal medicine
reviews.
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Cochrane reviews (n=39)

Other reviews (n=29)

Framing of question
23

39

Question specified
Narrow focus of question

38

1

17

Explicit testable hypothesis

22

Literature search
Adequate search description
15

Assessment for risk of missing
studies

24

31

8

Follow-up

32

7

Description of intervention

38

Tabulation of results

35

30.9 (3.7 - 256.2)

0.001

2.49 (0.8 - 7.0)

0.1

4.39 (0.4 - 44.5)

0.2

0.2 (0.1 - 0.7)

0.007

0.4 (0.1 - 1.3)

0.1
0.1

7

22

5.6 (1.9 - 16.4)

0.002

20.3 (1.1 - 381.3)

0.04

2.0 (0.7 - 6.1)

0.2

10.3 (3.2 - 33.0)

0.000

11.5 (2.1 -63.4)

0.005

17.5 (0.8 - 373.8)

0.07

5.2 (0.2 - 119.7)

0.3

3.7 (1.3 - 10.8)

0.02

38.1 (2.1 - 688.2)

0.01

6

19

10

8

18
11

7
3

27
12

2
16

17

27

0.04

0.4 (0.1 - 1.4)

13

9

25

20.3 (1.1 - 381.3)

22

2

36

P value

7

23

Data collection

Assessment for heterogeneity

19

39

Blinding of assessors

8

10

14

25

3

21

35

Potential sources of bias

Meta-analysis

26

32

4

Attempt to include unpublished data
Methods of review

22

1

7

Search without language restriction

13

16
7

38

Use of reference list

6

Odds ratio
(95% CI)

12

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Yes/Adequate

No/Inadequate/Not reported

Figure of
Quality
3 Cochrane and non Cochrane systematic reviews included in the study
Quality of Cochrane and non Cochrane systematic reviews included in the study.

restriction on the length of published non Cochrane
reviews by journals could have influenced their quality
scores. However this issue has been addressed by increase
in the web publishing of additional material in the electronic format by many journals in recent years.
This work has highlighted that literature searches in
reviews are currently generally poor. A search that is not
thorough risks giving biased inferences. We identified
considerable room for improvement in certain methodological features of non Cochrane reviews. However all the
selected reviews were similar in searches without language
restriction and assessment for risk of missing studies.
Interestingly use of reference list of the selected papers to
identify any other eligible studies for inclusion in the
review was found to be more frequent in non Cochrane
reviews (OR 0.2, 95% CI 0.1–0.7, p < 0.007). This could
be a result of the generic search strategy employed by
Cochrane reviews with unclear mention of the use of ref-

erence lists in individual reviews. Cochrane reviews were
found more likely to attempt to include unpublished data
compared to non Cochrane reviews (OR 5.6, 95% CI 1.9–
16.4, p < 0.002). This attempt to avoid publication bias is
significant as the odds of publication are higher if the
results are found to be significant compared to studies
with non-significant results.[76]
This study identified areas of maternal medicine that lack
good quality systematic reviews. Majority of the reviews
were on hypertensive disorders [8,10,11,17,19-23,3134,37,48,53,55,58,64,65,69,70],
psychiatry
[15,27,43,47,50-52,56,57,59,61,74,75], or thromboembolism [26,42,62-66,68]. Even among these commonly
addressed areas, a very narrow spectrum of diseases was
covered. For example reviews in psychiatry were solely
focussed on depression during pregnancy and reviews in
hypertension focussed mainly on pre eclampsia. Reviews
for some very common medical problems during preg-
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nancy were missing or of poor quality. We found very few
reviews on diabetes mellitus [12,39,49,73] and chronic
hypertension and none on thyroid disorders.
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